Looking forward to #SITC26! Excited to connect with colleagues and share the incredible immunotherapy research happening @MoffittNews. See you in Phoenix!
If your Author Accepted Manuscript was supported by @NIH funding, it must be posted publicly to PMC without an embargo. There's no cost and it does not require buying expensive open access plans. Take steps to upload your Author Accepted Manuscript here: https://t.co/mrmZO46sy4
And if you're interesting in joining us in our adventure into toxicity, germline genetics, and precision safety, consider applying to this open postdoctoral position.
We are recruiting a @USouthFlorida undergrad for an internship in artificial intelligence applied to mathematical oncology in my group @MoffittNews.
Interested candidates please send me an email with the details in the link:
https://t.co/6TXFKoqT6b
Really enjoyed talking about T cell exhaustion (and some other things!) with my friend @PatrickHwuMD on his fantastic Immunoverse Podcast!
https://t.co/JMyzc0ShGZ
Meeting the first patient who will receive proton therapy at @MoffittNews in just 10 days was a powerful reminder of why my work matters. Looking forward to beginning treatment and bringing this advanced technology closer to home for our community.
My group (EDIT lab) runs a Summer Seminar (EDIT SumS) for postdoc talks, similar to a journal club format. Here's a summary of our first in 2026:
https://t.co/5KnWmGN67A
Please RT: official post forthcoming, but for those currently hunting for postdocs, my group will have a fully funded position for an individual to lead our activities in computational analysis of radiographic data. If you have those skills and want to dream, please reach out.
@infoecho@domenjemec reviewed Conway's Law and the history of genome assemblers to see how including agents in academic labs will shape the research software ship. PIs will bifurcate further: either they'll ship more or end up even more removed. https://t.co/gHrjbJT0HB
As academic audit culture grows (now pre-approvals for conferences, foreign collabs, etc), I hope students will remember there's another way: academia built on mutual trust/obligation through collective effort
My take on the neoliberal academic ecosystem: https://t.co/zJhCta8sDD
At #MoffittScientificSymposium, Ada Lau shares research investigating immunosuppressive features of the multiple myeloma tumor microenvironment following CAR-T therapy. Findings revealed CD8+ immune responses between complete response and progressive disease samples, highlighting interferon pathway activation in responders and TNF-alpha signaling in progressive disease.
At #MoffittScientificSymposium, Ada Lau shares research investigating immunosuppressive features of the multiple myeloma tumor microenvironment following CAR-T therapy. Findings revealed CD8+ immune responses between complete response and progressive disease samples, highlighting interferon pathway activation in responders and TNF-alpha signaling in progressive disease.
Science does not have to be complicated: Direct injection of an immune therapy drug into tumour reduces side effects without compromising efficacy. https://t.co/PLwfA0Iv4i
"Why wait 6 months for reviewer 2 when you can get roasted by an #AI in seconds?" A metascientist's thought exercise.
https://t.co/NXQf1scf3f
Meanwhile, an AI society announces it's incorporating LLMs into its review process.
https://t.co/gI95hvg8Mg
On the lack of compelling evidence that medical AI is improving patient care, and what to do about it, a @NatureMedicine editorial https://t.co/kQiN6L2ai7
On the lack of compelling evidence that medical AI is improving patient care, and what to do about it, a @NatureMedicine editorial https://t.co/kQiN6L2ai7